MucoLox Formulation to Mitigate Mucositis Symptoms in Head/Neck Cancer
Status:
Recruiting
Trial end date:
2022-04-01
Target enrollment:
Participant gender:
Summary
This study will examine if the administration of prophylactic MucoLox formulation versus
sodium bicarbonate mouthwash in subjects with head/neck cancer receiving radiation ±
chemotherapy will result in significantly fewer subjects experiencing severe mucositis.